Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients ...
Q1 2026
May 11, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 6, 2025